DSRLF (Diasorin SpA) Accounts Payable & Accrued Expense : $0 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Accounts Payable & Accrued Expense?

Diasorin SpA's quarterly accounts payable & accrued expense increased from Sep. 2024 ($0 Mil) to Dec. 2024 ($183 Mil) but then declined from Dec. 2024 ($183 Mil) to Mar. 2025 ($0 Mil).

Diasorin SpA's annual accounts payable & accrued expense declined from Dec. 2022 ($218 Mil) to Dec. 2023 ($211 Mil) and declined from Dec. 2023 ($211 Mil) to Dec. 2024 ($183 Mil).

Diasorin SpA Accounts Payable & Accrued Expense Historical Data

The historical data trend for Diasorin SpA's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Accounts Payable & Accrued Expense Chart

Diasorin SpA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

186.43

202.23

217.82

211.04

182.90

Diasorin SpA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	143.79	-	182.90	-

Diasorin SpA Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

DIA:Italy DIAm:UK 0GZX:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).